Global Topical Hemostat Market Size, Share, Trends, Industry Growth by Type (Fibrin, Thrombin, Cellulose, Collagen, Gelatin, Adhesives, Others), by Application (General Surgery, Neurosurgery, Vascular Surgery, Cardiovascular Surgery, Others), by End-Use, by Region and Forecast to 2030

Report ID: RC158840 | Report Format: PDF + Excel | Starting Price: 3600/- USD |

The global topical hemostat market size was valued at around USD 6 billion in 2024 and projected to grow at a significant CAGR of over 9% during the forecast period from 2025 to 2030. The market is witnessing significant growth, driven by the increasing number of surgical procedures worldwide and the growing prevalence of chronic conditions requiring surgical interventions. Hemostatic agents play a crucial role in managing bleeding during surgeries, particularly in complex procedures such as cardiovascular, neurosurgery, and trauma care. Technological advancements in product formulations, such as the development of biocompatible and absorbable hemostats, are further boosting adoption. Key types of topical hemostats include fibrin, thrombin, cellulose, collagen, gelatin, and adhesives, each catering to specific surgical needs. Hospitals remain the primary end-users due to their higher surgical volume and advanced infrastructure, while ambulatory surgical centers are gaining traction with the increasing shift toward outpatient procedures.

The market is also fueled by rising investments in healthcare infrastructure, particularly in emerging economies, and the growing preference for minimally invasive surgeries that require efficient bleeding control. However, challenges such as high product costs and potential complications related to improper use may hinder growth in some regions. North America dominates the market due to advanced healthcare systems and the availability of innovative products, while the Asia-Pacific region is emerging as a lucrative market, driven by a large patient pool and increasing healthcare expenditure. As the demand for safer and more effective hemostatic solutions rises, the market is expected to experience sustained growth over the coming years.

Market Snapshot:

Benchmark Year 2024
Market Size ~ USD 6 Billion in 2024
Market Growth (CAGR) > 9% (2025 – 2030)
Largest Market Share North America
Analysis Period 2020-2030
Market Players BD, Johnson & Johnson, Baxter International Inc., Medtronic PLC, and Haemostatix Ltd.

Market Drivers:

The global topical hemostat market is primarily driven by the increasing prevalence of surgical procedures globally, owing to the rise in chronic diseases such as cardiovascular disorders, cancer, and orthopedic conditions. These conditions often require complex surgeries, which necessitate efficient bleeding control to prevent complications. The growing geriatric population, particularly in developed and emerging economies, further amplifies this trend as older individuals are more prone to surgeries due to age-related health issues. Additionally, the shift toward minimally invasive procedures has increased the demand for advanced hemostatic products that ensure precision, reduced blood loss, and quicker recovery times.

Technological advancements and product innovations are also key driving factors for the market. Leading manufacturers are focusing on developing biocompatible and absorbable hemostatic agents, such as fibrin sealants, collagen-based products, and gelatin sponges, which are designed to provide faster and more effective bleeding control. For example, recent launches of advanced hemostatic solutions with enhanced usability and safety profiles have expanded their applications across various surgical disciplines, including cardiovascular, neurosurgery, and general surgeries. Furthermore, the growing investments in healthcare infrastructure, especially in emerging economies, are creating new opportunities for market players to introduce innovative hemostatic solutions, ensuring sustained market growth.

Market Trends:

Shift Toward Minimally Invasive Surgeries: There is a growing global preference for minimally invasive surgical techniques, such as laparoscopic or endoscopic procedures, due to their numerous benefits. These include shorter recovery times, reduced risks of infection, smaller incisions, and less postoperative pain compared to traditional open surgeries. As a result, the demand for topical hemostats that can effectively manage bleeding in these more confined, delicate areas has increased. Hemostatic agents with enhanced precision and easy application are becoming critical to ensuring that these procedures are both safe and successful. As minimally invasive surgeries become more common across different specialties, the need for effective bleeding control agents like fibrin sealants, collagen sponges, and gelatin-based products continues to grow.

Innovation in Biocompatible and Absorbable Hemostats: In recent years, there has been a noticeable trend towards developing hemostatic products that are not only highly effective at controlling bleeding but are also biocompatible and absorbable. These agents are designed to minimize the need for removal after surgery, reducing the risk of complications and improving patient recovery times. As healthcare providers and surgeons aim to enhance patient outcomes, there is increasing demand for hemostatic solutions that break down naturally in the body without leaving foreign materials behind. This is especially crucial in surgeries involving sensitive tissues or organs, such as neurosurgery, where minimal foreign material is desired to avoid any adverse reactions. Biocompatible products offer a safer and more natural approach, making them an attractive choice for both surgeons and patients.

Increased Use of Gel-based and Fibrin-based Products: Fibrin and gelatin-based hemostats are becoming increasingly popular due to their excellent hemostatic properties, ability to support tissue healing, and natural origin. These products are highly effective in promoting clot formation and accelerating wound closure, which makes them ideal for a wide range of surgeries, including cardiovascular, orthopedic, and trauma surgeries. Fibrin-based products, for instance, are derived from human or animal plasma and mimic the body’s natural clotting process, providing effective bleeding control in surgeries with high blood loss. Gelatin-based hemostats are similarly gaining traction because they offer a biocompatible solution that is also absorbable, making them particularly useful in patients with complex medical conditions who may require multiple surgeries over time. The increasing reliance on these advanced hemostats reflects the demand for products that promote faster healing and better overall surgical outcomes.

Technological Advancements in Delivery Systems: The development of new delivery methods for topical hemostats is another trend driving growth in the market. Innovations such as pre-filled syringes, sprayers, and even powder-based applications are improving the ease of use and efficiency of hemostatic products. These advanced delivery systems ensure that the product is applied in the right amount, with minimal waste and more consistent results. In addition to improving the user experience for surgeons, these innovations also help in reducing surgical time and enhancing patient safety. The introduction of ready-to-use systems that allow for faster application, particularly in emergency or high-pressure surgical situations, is making hemostatic agents more accessible and easier to apply, further boosting their adoption in hospitals and surgical centers.

Growing Market in Emerging Economies: The demand for advanced surgical products, including topical hemostats, is seeing rapid growth in emerging markets such as Asia-Pacific, Latin America, and parts of Africa. This growth is driven by significant investments in healthcare infrastructure, improved access to medical treatments, and a rising middle class in these regions. As the healthcare systems in emerging economies improve, there is a greater emphasis on adopting cutting-edge medical technologies to meet the needs of a growing population with diverse healthcare needs. In particular, regions like Asia-Pacific are experiencing an increased demand for minimally invasive surgeries and advanced medical treatments, leading to higher consumption of hemostatic products. The expanding healthcare infrastructure, coupled with a growing awareness of advanced surgical solutions, is expected to further drive the market in these regions in the coming years.

Market Opportunities:

The Topical Hemostat Market is positioned to grow significantly, driven by the increasing prevalence of chronic diseases, which leads to a higher volume of surgical procedures. According to the World Health Organization (WHO), chronic diseases such as heart disease, diabetes, and cancer are responsible for nearly 71% of all deaths globally. This surge in chronic conditions is contributing to the rise in complex surgeries, which require advanced hemostatic solutions to manage bleeding effectively. As the demand for surgical interventions increases, the need for efficient and reliable bleeding control products is escalating, offering a lucrative opportunity for market players. Moreover, the growing preference for minimally invasive surgeries further fuels this trend, as these procedures require precise and efficient hemostatic agents to ensure optimal surgical outcomes.

In addition, the market is seeing significant opportunities through the development of novel hemostatic products that offer enhanced safety and efficacy. For instance, collagen-based hemostats have garnered increasing attention due to their biocompatibility and their ability to promote faster wound healing. These products are particularly beneficial in surgeries that demand effective tissue sealing, such as in orthopedic or neurosurgical procedures. With the rising use of advanced surgical techniques, including robotic-assisted surgeries, the demand for such innovative hemostatic agents continues to grow. Additionally, companies investing in research to create multifunctional hemostats with antimicrobial properties or the ability to deliver targeted drug therapies are likely to capitalize on these emerging opportunities.

Market Restraints:

The global topical hemostat market is hindered by several key restraining factors. One significant challenge is the high cost of advanced hemostatic products, which can be a barrier in regions with limited healthcare budgets. In emerging markets, where cost-effectiveness is a primary consideration, the high prices of some hemostatic agents may limit their adoption, with hospitals opting for more affordable, traditional alternatives. Furthermore, the regulatory approval process for new hemostatic technologies can be lengthy and complex, delaying product availability. The potential risk of adverse reactions or complications, particularly with animal-derived materials, may also deter some healthcare providers from adopting certain hemostatic agents.

Market Insights:

The global topical hemostat market is bifurcated into type, application, end-use, and geography. On the basis of application, the general surgery segment dominated the market with the largest market share of over 1/3 market in 2024, owing to the extensive range of procedures included under this category. General surgery covers a variety of surgeries, such as abdominal, gastrointestinal, and trauma-related interventions, all of which are prone to significant blood loss. According to the American College of Surgeons (ACS), approximately 15 million Americans undergo surgery each year, highlighting the large volume of general surgeries performed annually. This high frequency of surgeries drives a consistent demand for effective bleeding control solutions, ensuring that general surgery remains the leading segment in the market.

Additionally, the increasing preference for minimally invasive techniques in general surgeries, such as laparoscopic and robotic-assisted surgeries, further drives the demand for topical hemostats. These techniques, which involve smaller incisions, require precise and efficient hemostatic agents to minimize blood loss and ensure optimal surgical outcomes. The rising number of surgeries, combined with the growing adoption of advanced surgical methods, has solidified the position of general surgery as the dominant application segment in the topical hemostat market. With the global increase in surgical volume, particularly in aging populations and those with chronic conditions, the demand for hemostatic solutions in general surgery will continue to expand.

The topical hemostat market research report presents the analysis of each segment from 2020 to 2030 considering 2023 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2025 to 2030.

Historical & Forecast Period

  • 2020-23 – Historical Year
  • 2024 – Base Year
  • 2025-2030 – Forecast Period

Market Segmentation:

By Type:

  • Fibrin
  • Thrombin
  • Cellulose
  • Collagen
  • Gelatin
  • Adhesives
  • Others

By Application:

  • General Surgery
  • Neurosurgery
  • Vascular Surgery
  • Cardiovascular Surgery
  • Others

By End-Use Industry:

  • Food
  • Beverage
  • Beauty and Cosmetics
  • Healthcare
  • Chemicals
  • Consumer Goods
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Regional Analysis:

Geographically, the North America dominated the global topical hemostat market in 2024 with the largest revenue share of over 1/3 market share, primarily due to its advanced healthcare infrastructure, high surgical volume, and substantial healthcare spending. The United States, in particular, plays a significant role in driving market growth, as it has a high number of surgical procedures performed annually, with many of these surgeries requiring effective bleeding control solutions. The well-established healthcare system in North America and its consistent adoption of advanced medical technologies create a strong demand for topical hemostats across various surgical specialties.

In addition to the high volume of surgeries, the increasing prevalence of chronic diseases such as cardiovascular conditions, cancer, and diabetes in the region also contributes to the growth of the market. With the rise of minimally invasive surgeries, which require precise bleeding control during smaller incisions, the demand for advanced hemostatic agents continues to grow. North America’s leadership is further supported by the presence of key market players, innovation in hemostatic technologies, and a strong regulatory environment, ensuring the widespread adoption of hemostatic solutions in the region.

Competitive Landscape:

Some of the prominent market players operating in the global topical hemostat market are BD, Johnson & Johnson, Baxter International Inc., Medtronic PLC, and Haemostatix Ltd. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Recent Developments:

  • In July 2024, Teleflex Incorporated entered into two group purchasing agreements with Premier, Inc., enabling Premier members to access exclusive pricing on Teleflex’s hemostatic products, including QuikClot Hemostatic Dressings and Devices, which are designed to stop bleeding more rapidly than traditional gauze or laparotomy pads.
  • In April 2024, LifeScience PLUS launched DonorSeal, a 100% natural, plant-based cellulose matrix aimed at improving hemostasis and accelerating wound healing at donor sites. When it comes into contact with blood, DonorSeal forms a gel that creates a moist environment, promoting tissue regeneration. The product is absorbable, biodegradable, and safe for use across all age groups.

Key Companies:

  • BD
  • Johnson & Johnson
  • Baxter International Inc.
  • Medtronic PLC
  • Haemostatix Ltd.
  • Celox Medical
  • Pfizer Inc.
  • HemCon Medical Technologies Inc.
  • Integra LifeSciences
  • Teleflex Incorporated

Key Questions Answered by Topical Hemostat Market Report

  • Global topical hemostat market forecasts from 2025-2030
  • Regional market forecasts from 2025-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
  • Country-level forecasts from 2025-2030 covering 15 major countries from the regions as mentioned above
  • Topical hemostat submarket forecasts from 2025-2030 covering the market by type, application, end-use, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis about the market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level topical hemostat markets from 2025-2030
  • Competitive Landscape and market positioning of top 10 players operating in the market
Table of Contents:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Topical Hemostat Market Portraiture
2.2. Global Topical Hemostat Market, by Type, 2024 (USD Mn)
2.3. Global Topical Hemostat Market, by Application, 2024 (USD Mn)
2.4. Global Topical Hemostat Market, by End-Use, 2024 (USD Mn)
2.5. Global Topical Hemostat Market, by Geography, 2024 (USD Mn)

 

3. Global Topical Hemostat Market Analysis


3.1. Topical Hemostat Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Market Trends
3.5. Attractive Investment Proposition
3.6. Competitive Analysis
3.7. Porter’s Five Force Analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrants
3.7.4. Threat of Substitutes
3.7.5. Degree of Competition
3.8. PESTLE Analysis

 

4. Global Topical Hemostat Market by Type, 2020 – 2030 (USD Mn)


4.1. Overview
4.2. Fibrin
4.3. Thrombin
4.4. Cellulose
4.5. Collagen
4.6. Gelatin
4.7. Adhesives
4.8. Others

 

5. Global Topical Hemostat Market by Application, 2020 – 2030 (USD Mn)


5.1. Overview
5.2. General Surgery
5.3. Neurosurgery
5.4. Vascular Surgery
5.5. Cardiovascular Surgery
5.6. Others

 

6. Global Topical Hemostat Market by End-Use, 2020 – 2030 (USD Mn)


6.1. Overview
6.2. Hospitals
6.3. Ambulatory Surgical Centers
6.4. Others

 

7. North America Topical Hemostat Market Analysis and Forecast, 2020 – 2030 (USD Mn)


7.1. Overview
7.2. North America Topical Hemostat Market by Type, (2020-2030 USD Mn)
7.3. North America Topical Hemostat Market by Application, (2020-2030 USD Mn)
7.4. North America Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
7.5. North America Topical Hemostat Market by Country, (2020-2030 USD Mn)
7.5.1. U.S.
7.5.1.1. U.S. Topical Hemostat Market by Type, (2020-2030 USD Mn)
7.5.1.2. U.S. Topical Hemostat Market by Application, (2020-2030 USD Mn)
7.5.1.3. U.S. Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
7.5.2. Canada
7.5.2.1. Canada Topical Hemostat Market by Type, (2020-2030 USD Mn)
7.5.2.2. Canada Topical Hemostat Market by Application, (2020-2030 USD Mn)
7.5.2.3. Canada Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
7.5.3. Mexico
7.5.3.1. Mexico Topical Hemostat Market by Type, (2020-2030 USD Mn)
7.5.3.2. Mexico Topical Hemostat Market by Application, (2020-2030 USD Mn)
7.5.3.3. Mexico Topical Hemostat Market by End-Use, (2020-2030 USD Mn)

 

8. Europe Topical Hemostat Market Analysis and Forecast, 2020 - 2030 (USD Mn)


8.1. Overview
8.2. Europe Topical Hemostat Market by Type, (2020-2030 USD Mn)
8.3. Europe Topical Hemostat Market by Application, (2020-2030 USD Mn)
8.4. Europe Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
8.5. Europe Topical Hemostat Market by Country, (2020-2030 USD Mn)
8.5.1. Germany
8.5.1.1. Germany Topical Hemostat Market by Type, (2020-2030 USD Mn)
8.5.1.2. Germany Topical Hemostat Market by Application, (2020-2030 USD Mn)
8.5.1.3. Germany Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
8.5.2. U.K.
8.5.2.1. U.K. Topical Hemostat Market by Type, (2020-2030 USD Mn)
8.5.2.2. U.K. Topical Hemostat Market by Application, (2020-2030 USD Mn)
8.5.2.3. U.K. Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
8.5.3. France
8.5.3.1. France Topical Hemostat Market by Type, (2020-2030 USD Mn)
8.5.3.2. France Topical Hemostat Market by Application, (2020-2030 USD Mn)
8.5.3.3. France Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
8.5.4. Spain
8.5.4.1. Spain Topical Hemostat Market by Type, (2020-2030 USD Mn)
8.5.4.2. Spain Topical Hemostat Market by Application, (2020-2030 USD Mn)
8.5.4.3. Spain Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
8.5.5. Italy
8.5.5.1. Italy Topical Hemostat Market by Type, (2020-2030 USD Mn)
8.5.5.2. Italy Topical Hemostat Market by Application, (2020-2030 USD Mn)
8.5.5.3. Italy Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
8.5.6. Rest of Europe
8.5.6.1. Rest of Europe Topical Hemostat Market by Type, (2020-2030 USD Mn)
8.5.6.2. Rest of Europe Topical Hemostat Market by Application, (2020-2030 USD Mn)
8.5.6.3. Rest of Europe Topical Hemostat Market by End-Use, (2020-2030 USD Mn)

 

9. Asia Pacific Topical Hemostat Market Analysis and Forecast, 2020 - 2030 (USD Mn)


9.1. Overview
9.2. Asia Pacific Topical Hemostat Market by Type, (2020-2030 USD Mn)
9.3. Asia Pacific Topical Hemostat Market by Application, (2020-2030 USD Mn)
9.4. Asia Pacific Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
9.5. Asia Pacific Topical Hemostat Market by Country, (2020-2030 USD Mn)
9.5.1. China
9.5.1.1. China Topical Hemostat Market by Type, (2020-2030 USD Mn)
9.5.1.2. China Topical Hemostat Market by Application, (2020-2030 USD Mn)
9.5.1.3. China Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
9.5.2. Japan
9.5.2.1. Japan Topical Hemostat Market by Type, (2020-2030 USD Mn)
9.5.2.2. Japan Topical Hemostat Market by Application, (2020-2030 USD Mn)
9.5.2.3. Japan Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
9.5.3. India
9.5.3.1. India Topical Hemostat Market by Type, (2020-2030 USD Mn)
9.5.3.2. India Topical Hemostat Market by Application, (2020-2030 USD Mn)
9.5.3.3. India Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
9.5.4. South Korea
9.5.4.1. South Korea Topical Hemostat Market by Type, (2020-2030 USD Mn)
9.5.4.2. South Korea Topical Hemostat Market by Application, (2020-2030 USD Mn)
9.5.4.3. South Korea Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
9.5.5. Rest of Asia Pacific
9.5.5.1. Rest of Asia Pacific Topical Hemostat Market by Type, (2020-2030 USD Mn)
9.5.5.2. Rest of Asia Pacific Topical Hemostat Market by Application, (2020-2030 USD Mn)
9.5.5.3. Rest of Asia Pacific Topical Hemostat Market by End-Use, (2020-2030 USD Mn)

 

10. Latin America (LATAM) Topical Hemostat Market Analysis and Forecast, 2020 - 2030 (USD Mn)


10.1. Overview
10.2. Latin America Topical Hemostat Market by Type, (2020-2030 USD Mn)
10.3. Latin America Topical Hemostat Market by Application, (2020-2030 USD Mn)
10.4. Latin America Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
10.5. Latin America Topical Hemostat Market by Country, (2020-2030 USD Mn)
10.5.1. Brazil
10.5.1.1. Brazil Topical Hemostat Market by Type, (2020-2030 USD Mn)
10.5.1.2. Brazil Topical Hemostat Market by Application, (2020-2030 USD Mn)
10.5.1.3. Brazil Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
10.5.2. Argentina
10.5.2.1. Argentina Topical Hemostat Market by Type, (2020-2030 USD Mn)
10.5.2.2. Argentina Topical Hemostat Market by Application, (2020-2030 USD Mn)
10.5.2.3. Argentina Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
10.5.3. Rest of Latin America
10.5.3.1. Rest of Latin America Topical Hemostat Market by Type, (2020-2030 USD Mn)
10.5.3.2. Rest of Latin America Topical Hemostat Market by Application, (2020-2030 USD Mn)
10.5.3.3. Rest of Latin America Topical Hemostat Market by End-Use, (2020-2030 USD Mn)

 

11. Middle East and Africa Topical Hemostat Market Analysis and Forecast, 2020 - 2030 (USD Mn)


11.1. Overview
11.2. MEA Topical Hemostat Market by Type, (2020-2030 USD Mn)
11.3. MEA Topical Hemostat Market by Application, (2020-2030 USD Mn)
11.4. MEA Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
11.5. Middle East and Africa Topical Hemostat Market, by Country, (2020-2030 USD Mn)
11.5.1. GCC
11.5.1.1. GCC Topical Hemostat Market by Type, (2020-2030 USD Mn)
11.5.1.2. GCC Topical Hemostat Market by Application, (2020-2030 USD Mn)
11.5.1.3. GCC Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
11.5.2. South Africa
11.5.2.1. South Africa Topical Hemostat Market by Type, (2020-2030 USD Mn)
11.5.2.2. South Africa Topical Hemostat Market by Application, (2020-2030 USD Mn)
11.5.2.3. South Africa Topical Hemostat Market by End-Use, (2020-2030 USD Mn)
11.5.3. Rest of MEA
11.5.3.1. Rest of MEA Topical Hemostat Market by Type, (2020-2030 USD Mn)
11.5.3.2. Rest of MEA Topical Hemostat Market by Application, (2020-2030 USD Mn)
11.5.3.3. Rest of MEA Topical Hemostat Market by End-Use, (2020-2030 USD Mn)

 

12. Competitive Landscape


12.1. Company Market Share Analysis, 2023
12.2. Competitive Dashboard
12.3. Competitive Benchmarking
12.4. Geographic Presence Heatmap Analysis
12.5. Company Evolution Matrix
12.5.1. Star
12.5.2. Pervasive
12.5.3. Emerging Leader
12.5.4. Participant
12.6. Strategic Analysis Heatmap Analysis
12.7. Key Developments and Growth Strategies
12.7.1. Mergers and Acquisitions
12.7.2. New Product Launch
12.7.3. Joint Ventures
12.7.4. Others

 

13. Company Profiles


13.1. Becton, Dickinson and Company
13.1.1. Business Description
13.1.2. Financial Health and Budget Allocation
13.1.3. Product Positions/Portfolio
13.1.4. Recent Development
13.1.5. SWOT Analysis
13.2. Johnson & Johnson
13.3. Baxter International Inc.
13.4. Medtronic PLC
13.5. Haemostatix Ltd.
13.6. Celox Medical
13.7. Pfizer Inc.
13.8. HemCon Medical Technologies Inc.
13.9. Integra LifeSciences
13.10. Teleflex Incorporated
Fill the given form to inquiry before buying for Global Topical Hemostat Market Size, Share, Trends, Industry Growth by Type (Fibrin, Thrombin, Cellulose, Collagen, Gelatin, Adhesives, Others), by Application (General Surgery, Neurosurgery, Vascular Surgery, Cardiovascular Surgery, Others), by End-Use, by Region and Forecast to 2030 Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample
Inquiry Before Buying
Schedule a Call


Select License Type
$ 3600/- Single User License
$ 6995/- Corporate License

Paypal Certified Payment
For Any Assitance

Email: sales@researchcorridor.com
Why To Choose Us:
  • Markets in over 100+ countries analyzed granularly
  • 35% of our total client are returning clients
  • 1000+ customers globally
  • 100+ paid data sources mined to bring cutting-edge insights
  • 24x5 availability - we are always there when you need us
  • "Free of Cost Report Customization" is available
  • Request a regional report at Best Price

Impacts of COVID-19
COVID-19 Impact on the Global Topical Hemostat Market Size, Share, Trends, Industry Growth by Type (Fibrin, Thrombin, Cellulose, Collagen, Gelatin, Adhesives, Others), by Application (General Surgery, Neurosurgery, Vascular Surgery, Cardiovascular Surgery, Others), by End-Use, by Region and Forecast to 2030 Market


Our Clients